--- title: "Chanhen released its 2024 annual performance, with a net profit attributable to shareholders of 956 million yuan, an increase of 24.8%" type: "News" locale: "en" url: "https://longbridge.com/en/news/235231010.md" description: "Chanhen released its 2024 annual performance, with operating revenue of 5.906 billion yuan, a year-on-year increase of 36.72%; net profit attributable to the parent company of 956 million yuan, a year-on-year increase of 24.80%. Earnings per share are 1.7647 yuan, with a proposed cash dividend of 12 yuan for every 10 shares. Revenue from phosphoric acid and feed-grade dicalcium phosphate reached 3.317 billion yuan, setting a historical record, mainly due to the production launch of subsidiary projects, which drove an increase in sales volume" datetime: "2025-04-09T12:28:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/235231010.md) - [en](https://longbridge.com/en/news/235231010.md) - [zh-HK](https://longbridge.com/zh-HK/news/235231010.md) generator: "portal-rs" --- # Chanhen released its 2024 annual performance, with a net profit attributable to shareholders of 956 million yuan, an increase of 24.8% According to the Zhitong Finance APP, Chanhen (002895.SZ) released its 2024 annual report, showing an operating income of 5.906 billion yuan, a year-on-year increase of 36.72%. The net profit attributable to shareholders of the listed company was 956 million yuan, a year-on-year increase of 24.80%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 936 million yuan, a year-on-year increase of 23.01%. The basic earnings per share were 1.7647 yuan. In addition, it plans to distribute a cash dividend of 12 yuan (including tax) for every 10 shares to all shareholders. In 2024, the operating income from phosphoric acid and feed-grade dicalcium phosphate reached 3.317 billion yuan, setting a historical high; the operating income from monoammonium phosphate was 1.176 billion yuan, a year-on-year increase of 19.91%; mainly benefiting from the production launch of the subsidiary Guangxi Pengyue's "200,000 tons/year semi-hydrate and dihydrate wet-process phosphoric acid and deep processing" project, which significantly boosted product sales through capacity release ### Related Stocks - [002895.CN](https://longbridge.com/en/quote/002895.CN.md) ## Related News & Research - [Money Managers Turn Bullish On China Despite Mounting Economic Woes](https://longbridge.com/en/news/296554795.md) - [Planned Arctic Economic and Security Corridor All-Weather Road Positively Affects Sixty North Gold's Mon Gold Mine, NWT | SXNTF Stock News](https://longbridge.com/en/news/296360681.md) - [NRED Identifies Stronger Untested IP Targets Beyond 1.67% Copper Trench Mineralization at Wilmac | NREDF Stock News](https://longbridge.com/en/news/296612079.md) - [Lyntris valued at $1.8 billion after shares fall in New York debut](https://longbridge.com/en/news/296376207.md) - [InVert Graphite reports 32.2 Mt inferred resource at Morogoro graphite project in Tanzania](https://longbridge.com/en/news/296487529.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**